← Leaderboards
C. Richter King
Genvec, Inc.
$1,667,266
Attributed
$1,667,266
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $433.5K · FY2005–08$500K$375K$250K$125K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$1,667,266 · 5
By mechanism
R43$1,667,266 · 5
Top collaborators
No co-investigators on record.
Most similar at Genvec, Inc.
Same institution · by research overlap
- Duncan L McVey$3,069,048
- Lisa L Wei$1,941,075
- Jason Graham Gall$1,689,371
Others in their field
Top investigators on “Tumor Necrosis Factor Alpha”
- Dan M Cooper · University Of California San Diego$16,544,868
- Steven P Engebretson · Columbia University Health Sciences$11,509,123
- Craig J McClain · University Of Louisville$10,748,767
- John T McDevitt · University Of Maryland Baltimore$10,396,534
- Debra Lynn Laskin · Rutgers Biomedical And Health Sciences$10,232,985
- Cun-Yu Wang · University Of California Los Angeles$9,714,642
Research focus
Tumor Necrosis Factor AlphaTransfection /Expression VectorLaboratory MouseGene TherapyAdenoviridaeBiotechnologyReceptor BindingNonhuman Therapy EvaluationTherapy Design /DevelopmentNeoplasm /Cancer TherapyOvary NeoplasmsAthymic MouseIntegrinsDisease /Disorder ModelGene Delivery SystemLuciferin MonooxygenaseBiological Signal TransductionAntigens, ViralBinding SitesBaseAntigensAdenovirus VectorCytokine ReceptorsCoxsackievirus
Grant awards (7)
Preclinical Testing of an Adenoviral Vector based HSV-2 Vaccine$300,000
R43 · FY2008 · AI · contact PI
Novel Adenovirus Vectors for Biodefense Vaccines$433,476
R43 · FY2006 · AI · contact PI
Targeted, Alternate Serotype Vector for Ovarian Cancer$245,585
R43 · FY2005 · CA
Targeting Adenovirus Vectors to Ovarian Cancer$121,037
R43 · FY2005 · CA
Targeting Adenovirus Vectors to Ovarian Cancer$235,021
R43 · FY2004 · CA
Targeted, Alternate Serotype Vector for Ovarian Cancer$232,603
R43 · FY2004 · CA
Activation of the Immune System by TNFerade$99,544
R43 · FY2004 · CA